An Update on the Neuropsychology of HIV and Other Infectious Diseases

Wednesday, January 24, 2018
3:00pm - 4:30pm Eastern time
1.5 CE Credits

Presented by:
Steven Paul Woods, Psy.D.
Professor of Psychology
University of Houston

Clinical neuropsychologists are likely to encounter persons infected with HIV and other neurotropic viruses (e.g., hepatitis C), which may be the primary condition for a referral or an incidental risk factor for neurocognitive impairment. In this 90-minute webinar, we will provide an update on the neuropsychological aspects of infectious disease, focusing primarily on HIV. Specifically, we will critically review and discuss recent literature on: 1) changes in the epidemiology of HIV disease, which is increasingly affecting older adults; 2) brain systems involved in HIV infection; 3) the neuropsychological profile of HIV disease and the diagnosis of HIV-associated neurocognitive disorders; 4) the influence of common moderating factors, such as premorbid variables, psychiatric comorbidity, and co-infection with HCV on the expression of HIV-associated neurocognitive disorders; 5) HIV’s impact on health behaviors (e.g., medication adherence) and everyday functioning (e.g., household management); and 6) emergent pharmacological and rehabilitation efforts to manage HIV-associated neurocognitive disorders.

After the webinar, participants will be able to:

  1. Describe the recent changes in the epidemiology of HIV disease and the influence of infection and its comorbidities on brain structure and function.
  2. Explain the practical advantages and limitations of current approaches to diagnosing HIV-associated neurocognitive disorders.
  3. Discuss the effects of HIV-associated neurocognitive disorders on health behaviors (e.g., medication adherence) and everyday functioning (e.g., household management).

Target Audience: Clinical neuropsychologists

Instructional Level: Intermediate

NAN members login and non-members create an account to:



Registration closes 30 minutes prior to the live presentation.


Steven Paul Woods, Psy.D.
is a Professor of Psychology at the University of Houston, where he is the Director of the Cognitive Neuropsychology of Daily Life (CNDL) Laboratory. Dr. Woods also holds appointments as an Adjunct Professor at UC San Diego (Psychiatry) and the University of Western Australia (School of Psychological Science). His program of research uses cognitive theory to enhance the clinical detection, prediction, and remediation of real-world health outcomes in various neuropsychological populations, including HIV disease and aging. In particular, he is interested in how people’s ability to “remember to remember” (i.e., prospective memory) affects health-related behaviors such as adhering to medications. Dr. Woods is the Director of Clinical Neuropsychology Training at the University of Houston and is an active teacher, both in the classroom and in the laboratory. He is a licensed psychologist and operates an evidence-based neuropsychology clinic that serves HIV+ persons at the Thomas Street Health Center in Houston. Dr. Woods is a Fellow of the American Psychological Association (Division 40, Society for Clinical Neuropsychology) and the National Academy of Neuropsychology (NAN).
 

The Neuropsychology (Broadly Conceived) of MSA, PSP, and CBD

Wednesday, February 21, 2018
12:00pm - 1:30pm Eastern time
1.5 CE Credits

Presented by:
Adam Gerstenecker, Ph.D. 
Assistant Professor of Neurology
Division of Neuropsychology
The University of Alabama at Birmingham

The primary objective of this presentation will be to review the cognitive and behavioral features of the different atypical parkinsonian syndromes in which motor symptoms dominate early clinical symptomatology: multiple systems atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD). The impact of cognitive and behavioral deficits on quality of life, associations between neuropsychological and neuropsychiatric findings and brain imaging, and cognitive and behavioral symptom management are also discussed. Information included in this presentation was acquired through review of the available MSA, PSP, and CBD literature, with emphasis given to studies investigating the cognitive and behavioral features of the syndromes.

After the webinar, participants will be able to:

  1. Describe the neuropsychological features of MSA, PSP, and CBD.
  2. Explain the impact of neuropsychological features on quality of life in MSA, PSP, and CBD.
  3. Describe the current strategies for symptom management in MSA, PSP, and CBD.

Target Audience: Clinicians and researchers interested in the cognitive, behavioral, and functional aspects of MSA, PSP, and CBD

Instructional Level: Intermediate

NAN members login and non-members create an account to:



Registration closes 30 minutes prior to the live presentation.


Adam Gerstenecker, Ph.D. is an Assistant Professor of Neurology at the University of Alabama at Birmingham (UAB). Dr. Gerstenecker has expertise in atypical parkinsonisms in both clinical and research settings. His research in PSP has been funded by NIH/NIA and CurePSP. He has published a number of peer-reviewed papers on the cognitive, behavioral, and functional features of PSP and authored review papers and book chapters on the neuropsychological aspects of atypical parkinsonian disorders.

Motivational Interviewing and Neuropsychology: Enhancing Assessment, Feedback and Behavior Change for Persons and Families with Neuro-Cognitive Impairments

Wednesday, March 14, 2018
12:00pm - 1:30pm Eastern time
1.5 CE Credits

Presented by:
Mariann Suarez, Ph.D.
Chair, Medical Student Selection Committee
Associate Professor 
USF Health, Morsani College of Medicine

Neuropsychological practice entails the unique balance of diagnostic assessment and specialized feedback tailored to persons with neuro-cognitive impairments, as well as their families, and treatment teams involved in their care. As many recommendations involve helping the person cope with a loss of personal autonomy and make significant lifestyle changes, common practice challenges involve addressing issues of resistance, ambivalence to change, and non-adherence. One evidence-based method showing much promise in the past decade for improving these clinical practice challenges is Motivational Interviewing. Motivational Interviewing is collaborative and guides the conversational style used for strengthening a person’s own (intrinsic) motivation and commitment for change. While most neuropsychologists have a familiarity with Motivational Interviewing, there has been a lack of specificity for applications to their clinical and feedback practices. In this webinar, participants will learn about recent updates in applying Motivational Interviewing across clinical presentations with a range of populations, including youth and their parents as well as adult patients, and how it can be incorporated into treatment settings such as rehabilitation centers. Tips for using Motivational Interviewing to enhance adherence, assessment procedures, and collaborative feedback and to improve productive conversations will be highlighted.

After the webinar, participants will be able to:

  1. Describe the core components of Motivational Interviewing.
  2. Apply the 4-process model to neuropsychological assessment and feedback practices.
  3. Evoke and respond to change talk to enhance patients’ commitment to change.
  4. Improve treatment adherence and effective communications with persons and families with cognitive impairments.

Target Audience: This introductory-level webinar is designed for both practitioners and students working with persons with neuro-cognitive impairments. Familiarity with Motivational Interviewing is not required, and those with prior training in Motivational Interviewing will gain a deeper understanding of how they can consistently apply MI into their practice.

Instructional Level: Introductory

NAN members login and non-members create an account to:



Registration closes 30 minutes prior to the live presentation.


Mariann Suarez, Ph.D., ABPP
is an Associate Professor of Psychiatry and Behavioral Neurosciences at the Morsani College of Medicine, University of South Florida Health. A licensed Clinical Psychologist with Specialization in Pediatric Psychology, Dr. Suarez is Board Certified in Behavioral and Cognitive Psychology by the American Board of Behavioral and Cognitive Psychology and serves on the national board. As a Member of the Motivational Interviewing Network of Trainers for 15 years, her research focuses on the effectiveness of MI with persons using substances, applications of MI to Neuropsychology (Schoenberg & Scott, 2012), as well as with young people, co-authoring the first text on Motivational Interviewing with Adolescents and Young Adults (with Naar in 2011). Dr. Suarez has extensive national and international experience in the training and evaluation of MI with a range of trainees and practitioners, including the training of MI with medical students, health and community practitioners in various educational formats.